Study of SCY-635, Pegasys and Copegus in Hepatitis C

NCT01265511 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Infection

Interventions

DRUG: Placebo
DRUG: SCY-635
DRUG: Pegasys
DRUG: Copegus

Sponsor

Scynexis, Inc.